A March 2024 survey by McKinsey & Company showed that over 70% of healthcare leaders in the United States are either trying out or have already started using generative AI in their organizations. Most are still testing AI tools to see how useful they are before using them widely.
Among these healthcare groups, 59% work with third-party vendors to create custom AI solutions. This helps share knowledge and manage risks better. About 24% build AI tools inside their own teams. Only 17% buy AI products without many changes.
Nearly 60% of healthcare places using generative AI say they have or expect a positive return on investment (ROI). The ROI varies widely, from less than double to more than four times what they put in, based on how AI is used. The biggest benefits come from helping doctors and staff with documentation, diagnosis, and treatment planning. Improving patient engagement and making administration more efficient are also important.
Still, many healthcare organizations face big challenges that slow the wider use of generative AI.
Healthcare leaders have key worries about risks when using generative AI. These risks come from several areas:
Healthcare leaders know that risk control means more than just buying software. Experts say clear rules, processes, and safeguards must be in place. These help ensure AI is used ethically, rules are followed, and risks are managed.
Using AI well depends a lot on being technically ready. This means having the right tools and skills to support AI systems. Important parts include:
These technical steps help healthcare groups go from small tests to wider AI use.
One big way generative AI helps healthcare is by automating workflows, especially in front-office and administrative work. For example, Simbo AI uses AI to handle phone answering tasks that usually burden staff.
Automated phone systems can take calls about appointments, patient questions, and basic triage 24/7. This lowers staff workload and lets them focus on harder tasks. Benefits include:
Simbo AI uses advanced speech recognition and language understanding so automated calls feel natural and cover patient needs well. It also helps track calls properly to meet legal and ethical rules.
Automation like this helps healthcare practices reduce backlogs and boosts patient experience as they handle more demand for good and efficient care.
Most healthcare leaders pick a mixed approach to AI: using outside vendors alongside building some skills inside.
Working with experienced AI vendors offers tailored solutions and expert help. These partnerships assist with following rules, building safe systems, and fitting AI into current workflows. Companies like Dell Technologies provide AI tools and services that help with readiness, costs, and data security. Their open AI platforms allow flexibility for complex healthcare settings.
At the same time, having some internal AI skills gives organizations more control. Internal teams focus on preparing data, checking quality, and making sure AI fits their needs.
This two-part approach works well in the U.S. where following laws, keeping patients safe, and protecting data are top priorities.
Scaling generative AI in healthcare in the United States brings chances for improvement. But it also needs close attention to risks and readiness. Organizations that plan carefully are more likely to gain benefits in clinical work, operations, and finances. Medical practice administrators, owners, and IT managers must understand these factors to guide AI use and improve healthcare delivery.
Over 70% of healthcare leaders from various organizations are pursuing or have implemented generative AI capabilities.
Many organizations are in the proof-of-concept stage, testing AI tools to assess potential benefits and risks.
59% of organizations implementing generative AI are partnering with third-party vendors for customized solutions.
24% of healthcare organizations are building generative AI capabilities internally.
Key challenges include risk concerns, insufficient tech readiness, and unclear value of investments.
Healthcare organizations anticipate that AI will enhance clinical productivity, patient engagement, and administrative efficiency.
Nearly 60% of organizations that implemented generative AI report seeing or expecting a positive ROI.
Generative AI shows the highest potential value in clinical productivity and improving patient engagement.
Top risk concerns include regulatory uncertainties, inaccurate outputs, and potential biases in AI applications.
Establishing robust governance processes, frameworks, and guardrails is crucial for mitigating risks and ensuring compliance.